Stories > Affini-T Therapeutics at J.P. Morgan Healthcare Conference

Affini-T Therapeutics at J.P. Morgan Healthcare Conference

AB-2100 Phase 1/2 Trial Initiated

Abeona Therapeutics Grants Inducement Aw...

Adagene Advances Clinical Collaboration

Allogene Therapeutics Restates Financial...

Breakthrough Cancer Immunotherapy for Do...

Breakthrough Canine Cancer Treatment App...